Paper526006
LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.
Flournoy DJ and 1 other. Antimicrob Agents Chemother, 1979. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas. Papers, record 526006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526006
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacteria | Major topic |
| Klebsiella | |
| Microbial Sensitivity Tests | |
| Proteus | |
| Pseudomonas | |
| Serratia | |
| beta-Lactams |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 109,586 | Variation in response of Pseudomonas aeruginosa to combinations of gentamicin and carbenicillin. | J Okla State Med Assoc | 1979 | https://conductscience.org/library/papers/109586 | PubMed |
| 2 | 464,588 | Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/464588 | PubMed |
| 3 | 938,021 | Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/938021 | PubMed |
| 4 | 5,325,707 | Antibiotic susceptibility testing by a standardized single disk method. | Am J Clin Pathol | 1966 | https://conductscience.org/library/papers/5325707 | PubMed |
| 5 | 820,241 | In vitro evaluation of cefoxitin and cefamandole. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/820241 | PubMed |
| 6 | 727,759 | Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/727759 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,103,446 | Comparison of antimicrobial susceptibility patterns among coagulase-negative staphylococci. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7103446 | PubMed |
| 7,004,344 | Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7004344 | PubMed |
| 6,798,926 | Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6798926 | PubMed |
| 6,455,967 | Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6455967 | PubMed |
| 6,453,555 | Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6453555 | PubMed |
| 6,449,905 | Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935). | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6449905 | PubMed |
| 6,447,671 | In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria. | Infection | 1980 | https://conductscience.org/library/papers/6447671 | PubMed |
| 6,214,998 | Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6214998 | PubMed |
| 6,214,996 | Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6214996 | PubMed |
| 3,418,737 | Profile of patients from a Veterans Administration medical center. | J Natl Med Assoc | 1988 | https://conductscience.org/library/papers/3418737 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/526006
GET https://conductscience.org/api/papers/v1/526006/authors